HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5

Human papillomavirus (HPV) infection is a causative agent of cervical cancer (CC). N6-methyladenosine (m6A) modification is implicated in carcinogenesis and tumor progression. However, the involvement of m6A modification in HPV-involved CC remains unclear. Here we showed that HPV E6/7 oncoproteins a...

Full description

Bibliographic Details
Published in:	Pharmacological Research
Main Authors:	Fu-Chun Huo, Zhi-Man Zhu, Wen-Qi Du, Yao-Jie Pan, Xin Jiang, Meng-Jie Kang, Bo-Wen Liu, Jie Mou, Dong-Sheng Pei
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Subjects:	Cervical cancer M6A methylation DDX3 ALKBH5 PAK5
Online Access:	http://www.sciencedirect.com/science/article/pii/S1043661823002190

Similar Items

New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma
by: Mirko Rivara, et al.
Published: (2024-07-01)

ALKBH1 knockdown promotes the growth, migration and invasion of HTR-8/SVneo cells through regulating the m5C modification PSMD14
by: Caili Zhang, et al.
Published: (2025-03-01)

ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
by: Weijian Wang, et al.
Published: (2023-01-01)

The involvement of MALAT1-ALKBH5 signaling axis into proliferation and metastasis of human papillomavirus-positive cervical cancer
by: Suzhen Wu, et al.
Published: (2023-12-01)

m6A eraser ALKBH5 mitigates the apoptosis of cardiomyocytes in ischemia reperfusion injury through m6A/SIRT1 axis
by: Liangliang Liu, et al.
Published: (2023-05-01)

m6A eraser ALKBH5/treRNA1/DDX46 axis regulates BCR expression
by: Bandish Kapadia, et al.
Published: (2025-04-01)

The RNA Demethylases ALKBH5 and FTO Regulate the Translation of ATF4 mRNA in Sorafenib-Treated Hepatocarcinoma Cells
by: Pauline Adjibade, et al.
Published: (2024-08-01)

Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy
by: Ruijie An, et al.
Published: (2025-08-01)

ALKBH5 modulation of ferroptosis in recurrent miscarriage: implications in cytotrophoblast dysfunction
by: Chuanmei Qin, et al.
Published: (2024-10-01)

Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5
by: Yichun Ning, et al.
Published: (2020-11-01)

ALKBH5 induces macrophage activation to promote renal fibrosis via Retnla
by: Long Zheng, et al.
Published: (2025-12-01)

Complicated role of ALKBH5 in gastrointestinal cancer: an updated review
by: Weitong Shu, et al.
Published: (2024-08-01)

ALKBH5 involves in osteosarcoma tumor progression by mediating Notch signaling
by: Dagui Chen, et al.
Published: (2023-03-01)

N<sup>6</sup>-methyladenosine demethylase ALKBH5: a novel regulator of proliferation and differentiation of chicken preadipocytes
by: Zhang Qi, et al.
Published: (2021-12-01)

ALKBH5 regulates chicken adipogenesis by mediating LCAT mRNA stability depending on m6A modification
by: Xiaohuan Chao, et al.
Published: (2024-06-01)

Aging‐Associated ALKBH5‐m6A Modification Exacerbates Doxorubicin‐Induced Cardiomyocyte Apoptosis Via AT‐Rich Interaction Domain 2
by: Runtai Chen, et al.
Published: (2024-01-01)

RETRACTED: PAK5 facilitates the proliferation, invasion and migration in colorectal cancer cells
by: Silin Huang, et al.
Published: (2020-07-01)

Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification
by: Yiyang Hu, et al.
Published: (2022-02-01)

NEDD4L/RHOF axis suppresses the malignant phenotypes and lipid metabolism of breast cancer and NEDD4L is affected by upstream ALKBH5
by: Tao Liu, et al.
Published: (2025-09-01)

DDX54 drives ALKBH5-mediated demethylation of selected transcripts to suppress interferon antiviral response
by: Hao-Yu Sun, et al.
Published: (2025-09-01)

ALKBH5 alleviates lower extremity arteriosclerosis by regulating ITGB1 demethylation and influencing macrophage polarization
by: Zeyu Guan, et al.
Published: (2025-01-01)

ALKBH5, an m6A demethylase, attenuates tumor growth and inhibits metastasis in papillary thyroid carcinoma
by: Yong Zhuang, et al.
Published: (2025-01-01)

The crosstalk between the RNA demethylase, non‐coding RNAs, and transcription factors in gastric cancer: An ALKBH5 perspective
by: Fuda Xie, et al.
Published: (2023-04-01)

ALKBH5 in development: decoding the multifaceted roles of m6A demethylation in biological processes
by: Xinye Zhang, et al.
Published: (2025-08-01)

The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis
by: Ziwei Liao, et al.
Published: (2024-08-01)

Alkbh5 promotes Ythdf1 expression through demethylation thereby facilitating Fth1 translation to inhibit ferroptosis of myocardial infarction
by: Mingnan Yin, et al.
Published: (2025-04-01)

ALKBH5 regulates etoposide-induced cellular senescence and osteogenic differentiation in osteoporosis through mediating the m6A modification of VDAC3
by: Yansheng Huang, et al.
Published: (2024-10-01)

HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer
by: Daqin Suo, et al.
Published: (2024-04-01)

ALKBH5‐mediated m6A demethylation ameliorates extracellular matrix deposition in cutaneous pathological fibrosis
by: Ruoqing Xu, et al.
Published: (2024-09-01)

ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
by: Hehua Ma, et al.
Published: (2025-01-01)

RETRACTED ARTICLE: m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
by: Bo Tang, et al.
Published: (2020-01-01)

The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus
by: Qing Luo, et al.
Published: (2020-09-01)

Insights into the m6A demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development
by: Zewei Gao, et al.
Published: (2024-08-01)

ALKBH5 promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating TTI1 expression
by: Qimeng Chang, et al.
Published: (2024-03-01)

Pan-cancer analysis of the prognostic and immunological roles of DEAD-box helicase 5 (DDX5) in human tumors
by: Shixuan Liu, et al.
Published: (2022-10-01)

ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer
by: Chunting Chen, et al.
Published: (2023-11-01)

Exogenous Methylation Inhibitor 5‐Azacytidine Accelerates Postharvest Leaf Senescence in Pak Choi by Modulating Transcriptomic and Metabolomic Profiles
by: Dan Wang, et al.
Published: (2025-03-01)

ALKBH5/YTHDF2‐mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation
by: Yingjie Shao, et al.
Published: (2023-07-01)

ALKBH5 regulates arginase 1 expression in MDSCs and their immunosuppressive activity in tumor-bearing host
by: Lili Feng, et al.
Published: (2024-09-01)

Interactions between ALKBH5 and reader proteins in tumors: functions and molecular mechanisms
by: Jiahui Ou, et al.
Published: (2025-09-01)